Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

PDA Spectrophotometer

By Drug Discovery Trends Editor | March 29, 2010

Thermo Fisher Scientific Inc. launches the Evolution Array, a new UV-Visible (UV-Vis) spectrophotometer driven by photodiode array (PDA) technology that offers dramatic improvements in laboratory throughput.

Designed for fast acquisition of full-spectrum UV-Vis data, the Thermo Scientific Evolution Array delivers industry-leading performance for rapid and accurate method development and sample analysis in QA/QC, pharmaceutical, life science, materials science and educational laboratories.

The Evolution Array provides significant time advantages. By utilizing advanced photodiode array technology, the new instrument offers significant advantages with regards to full-spectrum data acquisition and sample throughput compared to traditional dispersive, monochromator-based spectrophotometers. Full spectrum data is acquired at less than one second for routine data applications and can be acquired at nearly 50 points per second for advanced kinetics applications.

The system provides simultaneous detection of all wavelengths throughout the UV and visible regions of the spectrum, allowing a nearly instantaneous display of a full absorbance spectrum from 190-1100 nm. Full-spectrum analysis of every standard and sample allows users to create standard curves, plot 3D graphical displays and examine samples at any wavelength at any time – greatly enabling analytical method development.

Featuring a mechanical shutter as its only moving part and a 10,000-hour tungsten lamp, the robust design of the Evolution Array enables longer uninterrupted operation, further increasing analytical speed. In addition, a complete line of accessories, including automated cell changers and temperature control and solid sample accessories, are available to facilitate system configuration according to specific laboratory requirements.

The Evolution Array operates on the Thermo Scientific VISIONcollect software to facilitate complete instrument and accessory control as well as efficient data collection, analysis and reporting. From routine quantitative analysis to 3D-spectrum kinetics, the software provides a spectrum radar visualization tool that allows users to view the entire active spectrum at a glance without interrupting work in the main display window. Additional advanced software options are available for life science, film thickness and color applications. For regulated laboratories, the VISIONcollect software is designed to enable data handling in accordance with 21 CFR Part 11 requirements.

Thermo Fisher Scientific Inc.


Filed Under: Drug Discovery

 

Related Articles Read More >

S&P report highlights Big Pharma’s concentration risk amid pre-JPM deal flurry
Eli Lilly in the Drug Discovery & Development Pharma 50
Lilly Phase 3b trial shows roughly 40-fold higher combined arthritis and weight-loss response
Drug companies sign “Most Favored Nation” deals, then raise prices anyway
New gonorrhea antibiotic could treat resistant infections
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE